Das Unternehmen Q-Med

Q-Med is a medical device company that develops, manufactures, markets and sells high quality medical implants for esthetic and medical use. The majority of the products are based on the companys patented technology, NASHA, for the production of stabilized non-animal hyaluronic acid.

The company today has approximately 650 co-workers in 20 countries, with approximately 400 at the company's head office and production facility in Uppsala. Q-Med AB is listed in the Mid Cap segment of the NASDAQ OMX Nordic.

Q-Med has as its overall objective high growth combined with good profitability. Q-Med shall consistently strive to meet its customers and other stakeholders expectations and needs, through constant improvements in quality and constant training. Q-Med also strives to give its shareholders a competitive return on their invested capital both in the short and long term.

www.restylane.de

www.macrolane.de

www.q-med.com